A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Design Study to Evaluate the Effects of Perhexiline on ECG Parameters in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2016
At a glance
- Drugs Perhexiline (Primary) ; Moxifloxacin
- Indications Hypertrophic cardiomyopathy
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Heart Metabolics Limited
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 01 Jul 2015 Status changed from recruiting to active, no longer recruiting as rep[orted by Australian New Zealand Clinical Trials Registry.
- 10 Feb 2015 New trial record